Champions Oncology(CSBR) - 2025 Q2 - Quarterly Results

Exhibit 99.1 Creating Greater Certainty In the Fight Against Cancer NEWS One University Plaza, Suite 307 Hackensack, NJ 07601 Tel: 551-206-8104 Champions Oncology Reports Quarterly Revenue of $13.5 Million Adjusted EBITDA of $1.1 million Hackensack, NJ – December 11, 2024 – Champions Oncology, Inc. (Nasdaq: CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, today announced its financial results for its second quarter of fiscal 2025, ended October 3 ...